S&P 500 Consumer Staples Sector SEC Filings — May 05, 2026

USA S&P 500 Consumer Staples

11 high priority39 medium priority50 total filings analysed

Executive Summary

Across 50 filings from diverse sectors (with Consumer Staples highlights in ADM, Fresh Del Monte, BellRing), results show mixed Q1/FY2026 performance: 65% reported revenue growth averaging +6% YoY (e.g., DuPont +4%, Exelixis +10%, Rockwell +12%), but 55% faced margin compression (avg -200bps, e.g., Atkore -780bps, BellRing gross -530bps) amid input costs, impairments, and one-offs. Capital allocation remains robust with $2B+ in buybacks/dividends (Emerson $2.2B FY, DuPont $275M ASR, KKR $317M), signaling shareholder focus despite $1B+ debt increases in some (Fresh Del Monte +$265M). Guidance raised in 30% (ADM EPS to $4.15-4.70, DuPont sales $7.155-7.215B), lowered in others (QuidelOrtho rev $2.70-2.75B); divestitures unlocked $2.5B+ value (DuPont Aramids $1.2B, Helix $107.5M). Consumer Staples theme: ADM outperforms with +48% Carbohydrate Solutions profit, but Fresh Del Monte -4.9% sales and BellRing volume gains offset by pricing declines signal volume vs. pricing tension. Portfolio trend: Industrials/mats resilient (Emerson margin +320bps), REITs/mortgages pressured (Granite Point net loss improved but portfolio -175M). Implications: Favor guidance-raisers with buybacks for near-term alpha; monitor margin trends and catalysts like Exelixis PDUFA Dec 2026.

Tracking the trend? Catch up on the prior S&P 500 Consumer Staples Sector SEC Filings digest from April 28, 2026.

Investment Signals(12)

  • Q1 net loss improved 43% YoY to $6M ($0.13/sh), legacy repayments $189.4M reduced portfolio risk, CECL reserve -160bps to 7.9%, $0.05 dividend

  • Q2 sales +3% YoY ($4.562B), pretax margin +320bps to 17.4%, FY guidance 4.5% sales growth/$6.45-6.55 adj EPS, $2.2B shareholder returns

  • Q2 sales +12% YoY ($2.239B organic +9%), adj EPS +32% to $3.30, FY sales 5-9% ($8.9B midpoint)/$12.50-13.10 adj EPS

  • Q1 gross margin +10bps to 8.5% on banana/pineapple prices, $0.30 dividend +$4M repurchases despite sales -4.9% [MIXED, SLIGHT BULLISH CAP ALLOC]

  • Q1 sales +4% YoY ($1.681B organic +2%), adj EPS +53% to $0.55, raised FY sales $7.155-7.215B/EBITDA $1.73-1.76B, $275M ASR + Aramids divest $1.2B

  • Q1 adj EPS +1% YoY to $0.71, Carbohydrate +48%/$356M/Nutrition +42%/$135M, raised FY adj EPS $4.15-4.70 from $3.60-4.25

  • DFIN(BULLISH)

    Q1 sales +2.2% YoY ($205.5M software +8.4%), Adj EBITDA +3.5% to $70.6M (34.4% margin +50bps), $28.3M repurchases + new $150M program

  • Exelixis(BULLISH)

    Q1 rev +10% YoY ($610.8M), cabozantinib +8% ($555M), new $750M buyback thru 2027, FY rev $2.525-2.625B

  • Farmer Mac(BULLISH)

    Record volume +17% YoY ($34.8B), net income +18% YoY ($51.8M/$4.75sh), core earnings +13%, $1.5B portfolio growth

  • Intapp(BULLISH)

    Q3 SaaS rev +27% YoY ($107.9M), Cloud ARR +31% ($459.3M), NRR 123%, FY SaaS $421-422M/non-GAAP NI $1.22-1.24/sh

  • Q2 vol +10.8% (Premier +11.3%), FY sales $2.325-2.365B/$315-335M EBITDA despite margin pressure [MIXED, VOLUMES BULLISH]

  • Q1 product sales +26% YoY ($54.9M Tavalisse +31%/$37.3M), FY rev $275-290M/positive NI reaffirmed

Risk Flags(8)

Opportunities(10)

  • Sold Aramids for $1.2B cash +$300M note/$325M equity, proceeds fund $275M ASR, organic sales flat but EBITDA +15%

  • ADM/Guidance Raise(OPPORTUNITY)

    EPS guide +17% midpoint to $4.4, biofuels/crushing recovery post-$275M MTM hit, Nutrition +42%

  • OCF $779M Q2 despite -6% YoY, FY OCF $4-4.1B, $1B buybacks/$1.2B divs, orders +15%

  • Intelligent Devices +13%/$1.008B, Software +20%/$684M, FY organic 5-9% at higher margins 22.5% (+350bps)

  • Zanzalintinib NDA accepted PDUFA Dec 3 2026, $750M buyback, rev guide $2.525-2.625B (+8-10% implied)

  • DFIN/Software Shift(OPPORTUNITY)

    Software sales +8.4% to 44.6% mix, Adj EBITDA margin +50bps to 34.4%, net leverage 0.8x, new $150M buyback

  • Farmer Mac/Volume Expansion(OPPORTUNITY)

    +17% to $34.8B (Renewables +80%), core cap $1.7B/13% Tier1, efficiency below target

  • Cloud ARR +31% to $459.3M/NRR 123%, FY non-GAAP OI $102.7-103.7M, op cash 9M +18% to $100.6M

  • Tavalisse/Rezlidhia +31% each, FY rev $275-290M/positive NI, R289 Phase1b H2 dose select

  • $800M 6.875% notes 2034 refi $400M 8.625% 2029 at lower coupon, conditional redemption

Sector Themes(6)

  • Mixed Revenue Growth w/ Margin Pressure

    32/50 filings show rev +avg 6% YoY (Rockwell +12%, Exelixis +10%), but 28/50 margins compressed avg -250bps (Atkore -780bps, BellRing -530bps) from costs/inflation/one-offs; implies cost control key for staples/industrials

  • Robust Capital Returns Amid Volatility

    22 companies announced $3B+ buybacks/divs (Emerson $2.2B FY, DuPont $275M ASR, DFIN $150M+), dividends in 15 (Fresh Del Monte $0.30 rec May19), signaling conviction despite mixed earnings

  • Guidance Dynamics Split

    15 raises (ADM +17% EPS midpoint, DuPont sales/EBITDA up), 5 cuts (QuidelOrtho EBITDA -6%), 10 reaffirms; ag/chem outperform (ADM/DuPont) vs diagnostics (Quidel -10% rev)

  • Divestitures Unlocking Value

    8 deals total $3B+ (DuPont $1.2B, Helix $107.5M, Granite $76M Chicago post-Q), reducing debt/portfolio risk (Fresh Del Monte realignment), focus on core (Helix deepwater)

  • Debt & Leverage Mixed

    Debt up in 12 (Fresh Del Monte +153%, Sunstone +$24M), but leverage low in others (DFIN net 0.8x, Angel Oak 1.3x), refinancings lower costs (Delek 6.875% vs 8.625%)

  • Consumer Staples Subset Resilient Volumes

    ADM Nutrition +42%, BellRing vol +10.8%/Premier +11.3%, Fresh Del Monte offset by divest/acquisition; pricing down 9% BellRing signals defensive volume play

Watch List(8)

  • $0.30/sh payable Jun11, record May19; monitor Del Monte integration post-Mar19 close, debt $438M impact

  • Adj EPS $1.65-1.70; earnings call May5 2026, watch underlying orders +15% sustain vs Europe/Asia declines

  • $275M accelerated repurchase imminent post-Aramids Apr1 close; FY guide $2.35-2.40 EPS, track Healthcare/Water trends

  • ADM/Crushing Recovery
    👁

    Q1 $(79M) vs +$47M prior, FY EPS $4.15-4.70; watch biofuels policy, Wilmar earnings -8%

  • Zanzalintinib NDA Dec3 2026 metastatic CRC; STELLAR-304 H2 2026, $590M prior SRP complete May2026

  • Sales 0-2% growth/$2.325-2.365B despite vol +10.8%; monitor price/mix -9%, inventory charges

  • FY rev $2.70-2.75B cut, NHSA concerns; LEX acquisition complete, High-Sens Troponin launch

  • SaaS $113.1-114.1M/total $149.1-150.1M; Cloud ARR $459M+31%, NRR 123% sustain

Filing Analyses(50)
Granite Point Mortgage Trust Inc.8-Kmixedmateriality 8/10

05-05-2026

Granite Point Mortgage Trust Inc. reported a Q1 2026 GAAP net loss attributable to common stockholders of $6.0 million ($0.13 per share), improved from $10.6 million ($0.22 per share) in Q1 2025, with Distributable Earnings Loss of $3.0 million ($0.06 per share) and flat net interest income of $8.0 million. The company achieved significant legacy loan repayments totaling $189.4 million, reducing the loan portfolio by a net $175.1 million to $1.6 billion in commitments, and post-quarter resolved a Chicago retail loan above carrying value, lowering CECL reserve from 9.4% to 7.9%; however, it held $98.2 million in REO properties and total assets declined to $1.54 billion from $1.76 billion at year-end. Book value stood at $7.05 per share, with a $0.05 common dividend declared and leverage at 1.7x.

  • ·Net loan portfolio activity of -$175.1 million: $189.4 million repayments/sales/amortization offset by $14.3 million fundings.
  • ·Specific repayments: $107.3 million Illinois multifamily, $67.0 million California retail, $12.9 million Hawaii hotel.
  • ·Post-quarter: Funded $2.1 million on existing commitments; resolved $76.0 million Chicago retail loan with $30.2 million write-off (previously reserved $31.3 million); sold Dallas office subordinate interest; extended Citibank facility to April 2027; cash at $55.6 million as of May 4, 2026.
  • ·98% floating rate portfolio; held 2 REO properties; Total Leverage Ratio 1.7x.
EMERSON ELECTRIC CO8-Kmixedmateriality 9/10

05-05-2026

Emerson reported second quarter FY2026 net sales of $4,562 million, up 3% YoY reported and 0.5% underlying, driven by Software & Systems (+4% reported) and Safety & Productivity (+5%), but Intelligent Devices grew only 2% reported and -1% underlying, with regional declines in Europe (-4%) and Asia, Middle East & Africa (-5%). Pretax earnings rose to $793 million with 320 bps margin expansion to 17.4%, and adjusted EPS increased 4% to $1.54 amid 15% underlying orders growth, though operating cash flow ($779 million) and free cash flow ($694 million) both declined 6% YoY. The company updated FY2026 outlook to ~4.5% net sales growth, adjusted EPS of $6.45-$6.55, operating cash flow $4.0B-$4.1B, and ~$2.2B cash return to shareholders via $1B repurchases and $1.2B dividends.

  • ·Six months FY2026 net sales $8,908M, up 3% YoY reported and 1% underlying.
  • ·Q2 FY2026 adjusted segment EBITA margin 27.6%, down 40 bps YoY.
  • ·FY2026 Q3 adjusted EPS guidance $1.65-$1.70; full year operating cash flow $4.0B-$4.1B.
  • ·Quarterly dividend $0.555 per share, payable June 10, 2026.
  • ·Total debt (short-term + long-term) increased to $13,359M from $13,116M as of Sept 30, 2025.
ROCKWELL AUTOMATION, INC8-Kmixedmateriality 9/10

05-05-2026

Rockwell Automation reported second quarter fiscal 2026 sales of $2,239 million, up 12% year over year (organic sales up 9%), with diluted EPS of $3.10 (up 40%) and adjusted EPS of $3.30 (up 32%). Intelligent Devices sales rose 13% to $1,008 million and Software & Control sales increased 20% to $684 million, while Lifecycle Services sales grew only 2% to $547 million (organic sales down 1%). The company updated fiscal 2026 guidance to 5%-9% reported and organic sales growth (midpoint ~$8.9B) and adjusted EPS of $12.50-$13.10, reflecting the exclusion of Sensia joint venture divestiture impacts.

  • ·Enterprise operating profit $504 million in Q2 FY26, up 32% YoY; margin 22.5% vs 19.0%.
  • ·Pre-tax margin 19.7% vs 14.9% YoY.
  • ·Q2 FY26 GAAP effective tax rate 20.2% vs 17.1%; adjusted 20.6% vs 17.7%.
  • ·ROIC 16.5% (GAAP) and 17.2% (adjusted) for 12 months ended March 31, 2026, vs 15.2% and 14.2% prior year.
  • ·Corporate and other expense $26 million vs $27 million YoY.
  • ·Amortization of acquisition-related intangibles $29 million vs $36 million YoY.
  • ·Sensia joint venture dissolved April 1, 2026; sales/earnings/cash flows excluded from H2 FY26 guidance.
FRESH DEL MONTE PRODUCE INC8-Kmixedmateriality 9/10

05-05-2026

Fresh Del Monte Produce Inc. reported Q1 FY2026 net sales of $1,044.1 million, down 4.9% YoY from $1,098.4 million, driven by the Mann Packing divestiture and avocado oversupply, partially offset by the Del Monte Foods acquisition. Gross margin improved slightly to 8.5% from 8.4%, supported by higher banana and pineapple prices, but operating income declined to $20.1 million from $44.9 million due to asset impairments and segment pressures including poultry/meats and prepared foods. FDP net income fell to $10.0 million ($0.21 diluted EPS) from $31.1 million ($0.64), though adjusted EPS was $0.63; the company supported shareholders with a $0.30 dividend and $4.0 million in repurchases.

  • ·Del Monte Foods acquisition closed March 19, 2026, leading to segment realignment including new Prepared Foods segment.
  • ·Quarterly dividend of $0.30 per share declared April 28, 2026, payable June 11, 2026 to shareholders of record May 19, 2026.
  • ·Long-term debt increased to $438.0 million from $173.0 million at FY2025 end due to acquisition financing.
  • ·Income from equity method investments: $6.6 million (up YoY due to fund liquidation distributions).
Kosmos Energy Ltd.8-Kmixedmateriality 9/10

05-05-2026

Kosmos Energy reported Q1 2026 record net production of ~74,800 boepd, up ~25% YoY, with revenues of $371 million and production expenses down ~22% YoY to $131 million; however, the company posted a net loss of $226 million ($0.45 per diluted share) and adjusted net loss of $36 million ($0.07 per share), exiting with $2.8 billion net debt. Key actions included a $350 million bond offering, $200 million equity raise, and agreement to sell Equatorial Guinea assets for up to $220 million, supporting debt reduction raised to ~20% for full-year 2026. Operational highlights feature GTA production exceeding nameplate capacity at ~2.85 mtpa gross and final investment decision on the Tiberius project.

  • ·GTA gross production ~2.85 mtpa exceeding 2.7 mtpa nameplate; 9.5 gross LNG cargos lifted Q1.
  • ·Ghana net production ~35,400 boepd; Jubilee gross oil ~70,000 bopd; TEN gross oil ~14,900 bopd.
  • ·Gulf of America net production ~16,800 boepd (~84% oil).
  • ·Equatorial Guinea gross production ~16,000 bopd; net ~5,600 bopd.
  • ·Oil hedges: 5.7 million barrels remainder 2026 at ~$66/bbl floor; 4.0 million barrels 2027 at ~$65/bbl floor.
  • ·Full-year 2026 capex guidance unchanged at $350 million.
  • ·RBL borrowing base to reduce to ~$1.2B post-Equatorial Guinea sale mid-2026.
  • ·Jubilee/TEN license extensions to 2040 ratified.
DuPont de Nemours, Inc.8-Kmixedmateriality 9/10

05-05-2026

DuPont reported strong Q1 2026 results with net sales of $1,681 million, up 4% YoY (2% organic), operating EBITDA of $414 million up 15% with margin expansion to 24.6%, and adjusted EPS of $0.55 up 53%, exceeding guidance and prompting a raise in full-year 2026 outlook to net sales of $7,155-$7,215 million, operating EBITDA of $1,730-$1,760 million, and adjusted EPS of $2.35-$2.40. Healthcare & Water Technologies grew organic sales 3%, but Water Technologies declined low to mid-single digits due to logistics disruptions; Diversified Industrials organic sales were about flat, with Building Technologies down low-single digits. The company completed the Aramids divestiture and announced a $275 million accelerated share repurchase.

  • ·Completed Aramids divestiture on April 1, 2026, to Arclin for $1.2 billion cash (subject to adjustments), $300 million note receivable, and $325 million equity interest.
  • ·Q1 2026 cash provided by operating activities $232 million; capital expenditures $102 million; transaction-adjusted free cash flow conversion 65%.
  • ·Announces $275 million accelerated share repurchase to launch imminently.
  • ·Q2 2026 guidance: net sales ~$1,800 million, operating EBITDA ~$430 million, adjusted EPS ~$0.59 (organic sales growth ~3%).
  • ·Plans to seek stockholder approval for reverse stock split (1-for-2 to 1-for-4) at 2026 Annual Meeting.
Archer-Daniels-Midland Co8-Kmixedmateriality 9/10

05-05-2026

ADM reported Q1 2026 net earnings of $298 million and adjusted EPS of $0.71, up 1% YoY, with total segment operating profit rising 2% to $764 million driven by strong growth in Carbohydrate Solutions (+48% to $356 million) and Nutrition (+42% to $135 million). However, Ag Services & Oilseeds declined 34% to $273 million due to $275 million in net negative mark-to-market and timing impacts. The company raised its full-year 2026 adjusted EPS guidance to $4.15-$4.70 from $3.60-$4.25, supported by biofuels policy clarity and progress in crushing and ethanol businesses.

  • ·Crushing subsegment operating profit $(79) million in Q1 2026 vs $47 million in Q1 2025 (NM change)
  • ·Refined Products and Other subsegment operating profit $86 million in Q1 2026 vs $134 million in Q1 2025 (-36%)
  • ·Wilmar equity earnings $66 million in Q1 2026 vs $72 million in Q1 2025 (-8%)
  • ·Starches and Sweeteners subsegment operating profit $229 million in Q1 2026 vs $207 million in Q1 2025 (+11%)
  • ·Vantage Corn Processors subsegment operating profit $127 million in Q1 2026 vs $33 million in Q1 2025 (NM)
  • ·Human Nutrition subsegment operating profit $104 million in Q1 2026 vs $75 million in Q1 2025 (+39%)
  • ·Animal Nutrition subsegment operating profit $31 million in Q1 2026 vs $20 million in Q1 2025 (+55%)
  • ·Oilseed tonnage produced increased 2% YoY in Q1 2026
  • ·Conference call webcast on May 5, 2026 at 7:30 a.m. Central Time
Atkore Inc.8-Kmixedmateriality 9/10

05-05-2026

Atkore Inc. reported Q2 FY2026 net sales of $731.4 million, up 4.2% YoY, driven by 5% organic volume growth, with Electrical segment sales rising 8.1% to $532.5 million; however, Adjusted EBITDA fell 30.4% to $81.1 million, with Electrical down 18.2% and Safety & Infrastructure down 52.0% to $17.3 million due to higher input costs outpacing price increases, while gross margin declined to 18.6% from 26.4%. Net loss widened to $124.1 million from $50.1 million, impacted by $136.5 million litigation settlements and other one-time charges. The company divested its HDPE Pipe & Conduit and Belgian coatings businesses, maintaining FY2026 Adjusted EBITDA outlook of $340-360 million.

  • ·Approved quarterly dividend of $0.33 per share, payable May 29, 2026 to stockholders of record May 19, 2026.
  • ·FY2026 outlook: Adjusted EBITDA $340-360 million; Adjusted net income per diluted share $5.05-$5.55.
  • ·Retained 10% equity stake in combined entity post-HDPE divestiture.
  • ·Conference call held May 5, 2026 at 8 a.m. ET.
CANADIAN DERIVATIVES CLEARING CORP8-Kneutralmateriality 3/10

05-05-2026

Canadian Derivatives Clearing Corporation (CDCC) filed an 8-K on May 5, 2026, reporting under Item 9.01 with Exhibit 99.1, providing an updated list of underlying interests for options listed on the Montreal Exchange and offered for sale in the United States pursuant to its Form S-20 registration statement as of April 30, 2026. The exhibit details equity options on over 150 Canadian companies and trusts (e.g., 5N Plus Inc. (VNP), Bank of Montreal (BMO), Shopify Inc. (SHOP)); index options on S&P/TSX 60 (SXO), Capped Utilities (SXV), and Banks (SXJ); options on closed-end funds (CEFs) like Sprott Physical Gold Trust (PHYS); Canadian Depositary Receipts (CDRs) for U.S. equities such as Nvidia (NVDA), Tesla (TSLA); and options on numerous ETFs including BMO S&P/TSX Capped Composite Index ETF (ZCN) and CI Galaxy Bitcoin ETF (BTCX). No financial performance metrics, changes, or comparisons are reported.

Delek Logistics Partners, LP8-Kpositivemateriality 8/10

05-05-2026

Delek Logistics Partners, LP and its subsidiary Delek Logistics Finance Corp. priced an offering of $800 million aggregate principal amount of 6.875% senior notes due 2034. Concurrently, they issued a conditional notice of partial redemption for $400 million aggregate principal amount of their outstanding 8.625% Senior Notes due 2029 at a redemption price of 104.313% of principal plus accrued interest. The redemption is conditioned on the consummation of the new notes offering, representing a refinancing at a lower coupon rate with no other performance metrics reported.

  • ·Event reported on May 4, 2026
  • ·Press release issued in accordance with Rule 135(c) under the Securities Act of 1933
  • ·Redemption excludes accrued and unpaid interest to redemption date
HELIX ENERGY SOLUTIONS GROUP INC8-Kpositivemateriality 8/10

05-05-2026

Helix Energy Solutions Group, Inc. (NYSE: HLX) sold all equity interests in its Gulf of America-focused Shallow Water Abandonment business to C-Dive, LLC (Chouest group) for $107.5 million cash at closing, adjustable for working capital and other expenses; the deal was signed and closed on May 1, 2026. This divestiture sharpens Helix's strategic focus on deepwater well intervention, decommissioning, robotics, and offshore services, aligning with its proposed merger with Hornbeck Offshore Services, Inc. No declines or flat metrics are reported in the announcement.

  • ·Transaction supports focus on deepwater operations, robotics, well intervention, and decommissioning
  • ·Helix achieved record financial performance in the divested business since acquisition
  • ·SEC filings referenced: Form 10-K (filed Feb 26, 2026), 10-Qs, proxy for 2026 annual meeting (filed Apr 1, 2026), upcoming Form S-4
Eloxx Pharmaceuticals, Inc.10-Qmixedmateriality 7/10

05-05-2026

Eloxx Pharmaceuticals reported a widened net loss of $3,754 thousand for the three months ended March 31, 2026, compared to $1,709 thousand in the prior year period, driven by significantly higher operating expenses including research and development at $1,659 thousand (up from $510 thousand) and general and administrative at $2,136 thousand (up from $712 thousand). Cash and cash equivalents increased to $6,363 thousand from $4,785 thousand at December 31, 2025, supported by $7,031 thousand in net financing proceeds primarily from pre-funded warrants. However, net cash used in operating activities rose sharply to $5,453 thousand from cash provided of $1,204 thousand in the prior year, indicating elevated cash burn.

  • ·Weighted average shares used in net loss per share increased to 48,210,071 in Q1 2026 from 3,805,550 in Q1 2025.
  • ·Warrants outstanding increased to 55,102,631 as of March 31, 2026 from 38,776,102 at December 31, 2025.
  • ·Domicilium debt conversion: principal of $1,000 and accrued interest of $56 converted to pre-funded warrants.
  • ·Stockholders’ deficit improved to $(7,584) thousand from $(11,907) thousand.
Harel Insurance Investments & Financial Services Ltd.13F-HRneutralmateriality 6/10

05-05-2026

Harel Insurance Investments & Financial Services Ltd. filed its 13F-HR on May 5, 2026, disclosing U.S. equity holdings as of March 31, 2026, with no reported changes in positions from prior periods in this filing. Key holdings include Alphabet Inc. Class A (713758 thousand USD value, 2482119 shares), Apple Inc. (589035 thousand USD, 2320981 shares), Amazon.com Inc. (406447 thousand USD, 1951562 shares), Camtek Ltd. (349008 thousand USD, 2302009 shares), and Broadcom Inc. (227960 thousand USD, 736534 shares). The filing notes that portions are held through subsidiaries like Harel Insurance Company Ltd. and others, with disclaimers on beneficial ownership beyond pecuniary interest.

  • ·Report period end date: 2026-03-31
  • ·Filing as of date: 2026-05-05
  • ·Securities partially held for public through provident funds, mutual funds, pension funds, and insurance policies managed by subsidiaries
  • ·Subsidiaries operate under independent management with independent voting and investment decisions
KKR & Co. Inc.8-Kmixedmateriality 9/10

05-05-2026

KKR reported strong Q1 2026 results with Fee Related Earnings up 24% YoY to $1.0 billion, Total Operating Earnings up 19% YoY to $1.3 billion, and Adjusted Net Income up 21% YoY to $1.2 billion, alongside AUM growth of 14% YoY to $758 billion and $28 billion in new capital raised. However, transaction and monitoring fees declined 3% YoY to $253 million, net realized investment income fell 44% YoY to $104 million, and quarterly new capital raised was slightly below prior year at $28 billion versus $31 billion. The company repurchased $317 million in shares and closed the acquisition of Arctos Partners with $16 billion AUM post-quarter.

  • ·Share repurchase: 3.5 million shares at average $91.08 per share.
  • ·Regular dividend declared: $0.195 per share, up 5% annualized from 2025.
  • ·Conference call: May 5, 2026 at 10:00 a.m. ET.
  • ·GAAP Revenues: $4,317,983 thousand Q1 2026, up from $3,110,183 thousand Q1 2025.
AMERICAN ELECTRIC POWER CO INC8-Kmixedmateriality 9/10

05-05-2026

AEP reported Q1 2026 GAAP earnings of $874 million ($1.61 per share), up from $800 million ($1.50 per share) in Q1 2025, and operating earnings of $891 million ($1.64 per share), up from $823 million ($1.54 per share), with revenue increasing to $6,020 million from $5,463 million. The company reaffirms 2026 operating EPS guidance of $6.15-$6.45 and raised its five-year capital plan to $78 billion from $72 billion, driven by 63 GW new load by 2030; however, AEP Transmission Holdco earnings declined to $209 million from $235 million, and Generation & Marketing fell to $75 million from $102 million (GAAP). Strong growth in Vertically Integrated Utilities (+$138 million) and Transmission & Distribution Utilities (+$72 million) was partially offset by these declines.

  • ·Vertically Integrated Utilities GAAP earnings increased $138 million to $462 million YoY.
  • ·Transmission & Distribution Utilities GAAP earnings increased $72 million to $237 million YoY.
  • ·AEP Transmission Holdco operating earnings declined $26 million to $209 million YoY.
  • ·Generation & Marketing operating earnings increased $14 million to $90 million YoY (non-GAAP).
  • ·All Other operating loss widened $79 million to -$109 million YoY.
  • ·Weighted average basic shares outstanding: 542 million in Q1 2026 vs 533 million in Q1 2025.
  • ·Nearly $600 million in customer savings from federal grants and loans.
BELLRING BRANDS, INC.8-Kmixedmateriality 8/10

05-05-2026

BellRing Brands reported Q2 FY2026 net sales of $598.7 million, up 1.8% YoY driven by 10.8% volume growth but offset by 9.0% decline in price/mix; however, operating profit fell to $66.0 million, Adjusted EBITDA dropped to $53.8 million, and margins were pressured by an $11.3 million inventory charge, higher freight, and input inflation. Premier Protein sales grew 1.7% with 11.3% volume increase, while Dymatize sales declined 1.9% on 6.8% volume drop. The company updated FY2026 outlook to net sales of $2.325-$2.365 billion (0-2% growth) and Adjusted EBITDA of $315-$335 million, and repurchased 1.2 million shares for $26.2 million.

  • ·Q2 FY2026 gross profit margin declined to 27.0% from 32.3% YoY.
  • ·Six months FY2026 Adjusted EBITDA of $144.1 million, down from $243.9 million YoY.
  • ·Interest expense net increased to $20.1 million in Q2 FY2026 from $16.5 million YoY due to higher borrowings.
  • ·Chief Executive Officer external search is progressing.
  • ·Conference call scheduled for May 5, 2026 at 8:30 a.m. ET.
Donnelley Financial Solutions, Inc.8-Kpositivemateriality 9/10

05-05-2026

DFIN reported first-quarter 2026 net sales of $205.5 million, up 2.2% YoY from $201.1 million, driven by 8.4% growth in software solutions net sales to $91.7 million (44.6% of total), though partially offset by lower capital markets and investment companies compliance revenue due to reduced demand for printed materials. Net earnings increased 8.1% to $33.5 million ($1.27 per diluted share), Adjusted EBITDA rose 3.5% to $70.6 million (34.4% margin, up 50 bps), and cash flows improved significantly with operating cash flow at ($5.6) million (vs. ($37.7) million) and free cash flow at ($16.0) million (vs. ($51.0) million), albeit still negative. The company repurchased 594,782 shares for $28.3 million and authorized a new $150 million share repurchase program.

  • ·Gross leverage of 0.9x and net leverage of 0.8x as of March 31, 2026.
  • ·Q2 2026 guidance: total net sales $215M to $225M, Adjusted EBITDA margin 34% to 36%, capital markets transactional net sales $40M to $45M.
  • ·Conference call scheduled for May 5, 2026 at 9:00 a.m. Eastern time.
  • ·Previous share repurchase authorization had $25.5 million remaining as of March 31, 2026.
Angel Oak Mortgage REIT, Inc.8-Kmixedmateriality 9/10

05-05-2026

Angel Oak Mortgage REIT reported Q1 2026 GAAP net loss of $(7.4) million, or $(0.30) per diluted share, due to $14.3 million in net realized and unrealized losses, despite net interest income rising 20.1% YoY to $12.1 million from $10.1 million and 11.2% QoQ from $10.9 million. GAAP book value per share declined 4.0% to $10.31 and economic book value fell 3.3% to $12.28 compared to year-end 2025. The company executed a $272.3 million securitization reducing debt by $234.1 million, purchased $246.2 million in new loans, and declared a $0.32 per share dividend payable May 29, 2026.

  • ·Recourse debt to equity ratio of 1.3x as of March 31, 2026.
  • ·Weighted average coupon of residential whole loans portfolio increased 24 basis points to 7.62% from Dec 31, 2025.
  • ·Purchased loans had weighted average CLTV of 67.1% and non-zero FICO of 759.
SelectQuote, Inc.8-Kmixedmateriality 9/10

05-05-2026

SelectQuote, Inc. reported Q3 FY26 consolidated revenue of $430.9 million, up 5.5% YoY from $408.2 million, net income of $40.2 million (up 54.6% from $26.0 million), and Adjusted EBITDA of $44.6 million (up 18.3% from $37.7 million). Segment performance was mixed: Senior revenue grew 8% YoY to $182.9 million with Adjusted EBITDA up 28% to $58.6 million, but 9-month revenue declined 3%; Healthcare Services revenue rose 5% to $199.4 million though Adjusted EBITDA fell 18% to $5.3 million; Life revenue increased 4% to $47.9 million but Adjusted EBITDA dipped 4% to $6.1 million. The company reaffirmed FY26 guidance of $1.61-$1.71 billion in revenue and $90-$100 million in Adjusted EBITDA.

  • ·Submitted Medicare Advantage policies: 196,970 in Q3 FY26 (-2% YoY)
  • ·Senior Adjusted EBITDA margin: 32% in Q3 FY26 (up from 27%)
  • ·Healthcare Services SelectRx members grew 11% YoY to 116,616 as of Mar 31, 2026
  • ·Combined Senior/Healthcare revenue/CAC multiple improved to 6.7x trailing 12 months ended Mar 31, 2026 from 5.8x
  • ·Receivables balance grew nearly $50 million over past year to nearly $1 billion
  • ·Earnings conference call scheduled for May 5, 2026 at 8:30 a.m. ET
Livforsakringsbolaget Skandia, Omsesidigt13F-HRneutralmateriality 5/10

05-05-2026

Livforsakringsbolaget Skandia, Omsesidigt filed its 13F-HR on May 5, 2026, reporting U.S. equity holdings as of March 31, 2026, with all positions held under sole voting power. Top holdings by market value include Apple Inc. at $25,179,328 (99,268 shares), Amazon.com Inc. at $13,387,161 (64,281 shares), Alphabet Inc. Class A at $11,161,340 (38,818 shares), and Alphabet Inc. Class C at $9,341,989 (32,580 shares). The portfolio spans diverse sectors including technology, finance, and healthcare, with some positions like Baxter International reduced to zero shares.

  • ·Report period end date: March 31, 2026
  • ·All listed holdings (over 300 positions) held with sole voting power and no shared power reported
  • ·Portfolio includes diverse sectors: technology (e.g., Apple, Amazon), communications (e.g., Alphabet, Meta), and financials (e.g., JPMorgan)
Climb Bio, Inc.8-Kneutralmateriality 6/10

05-05-2026

Climb Bio, Inc. announced a virtual investor event on May 5, 2026, at 8:00 a.m. ET, focused on budoprutug, its clinical-stage anti-CD19 monoclonal antibody in development for primary membranous nephropathy, immune thrombocytopenia, and systemic lupus erythematosus. Press release (Exhibit 99.1) and presentation (Exhibit 99.2) are attached, with a live webcast and replay available on the company's website.

  • ·Event webcast and replay under 'News & Events' section of climbbio.com; website info not part of filing
  • ·Item 7.01 information, including exhibits, not deemed 'filed' under Section 18 of Exchange Act or subject to liabilities
IPG PHOTONICS CORPDEFA14Aneutralmateriality 3/10

05-05-2026

IPG Photonics Corporation (IPGP) filed Definitive Additional Proxy Materials (DEFA14A) on May 05, 2026, pursuant to Section 14(a) of the Securities Exchange Act of 1934 and Rule 14a-12. The filing indicates no fee was required and is marked as Definitive Additional Materials. No specific proposals, financial data, or voting matters are detailed in the provided content.

Momentus Inc.8-Kpositivemateriality 9/10

05-05-2026

Momentus successfully launched Vigoride 7 on March 30, 2026, carrying 10 payloads under contracts including $4.2 million with DARPA and $1.9 million with SpaceWERX, with operations ongoing for several months. The company forecasts 2026 revenue of $10.0 million, a 9X increase from $1.1 million in 2025, bolstered by cash rising to $26.2 million as of April 23, 2026 from $12.8 million at 2025 year-end, full retirement of $1.35 million convertible debt, and a $5 million private placement closed April 16, 2026. Vigoride 8 for 2027 is fully subscribed with NASA contracts, amid expanding government opportunities like the $151 billion SHIELD IDIQ.

  • ·Vigoride 7 launched March 30, 2026 on SpaceX Transporter 16 from Vandenberg Space Force Base.
  • ·New San Jose facility quadruples clean room capacity from 4,500 to 16,000 square feet.
  • ·Momentus holds Top Secret clearance and right to compete in $151B SHIELD IDIQ tied to Golden Dome.
  • ·FY2025 Annual Report filed March 31, 2026.
State of New Jersey Common Pension Fund D13F-HRneutralmateriality 4/10

05-05-2026

State of New Jersey Common Pension Fund D disclosed its quarterly 13F-HR holdings as of March 31, 2026, reporting 1549 positions with a total value of $25927076128 across various equities held solely. Top holdings by share count include Apple Inc. (5024674 shares), Amazon.com Inc. (3290326 shares), AT&T Inc. (2430617 shares), Bank of America Corp. (2357682 shares), and Alphabet Inc. Cap Stk Cl A (1986061 shares). The filing was submitted on May 05, 2026, and signed by Shoaib Khan, Director; no changes or performance metrics relative to prior periods were provided.

  • ·All reported holdings held with sole voting and dispositive power (no shared or none reported)
  • ·Fiscal year end: 0630
  • ·SEC file number: 028-13667
  • ·Public document count: 2
Federal Home Loan Bank of Chicago8-Kneutralmateriality 6/10

05-05-2026

The Federal Home Loan Bank of Chicago disclosed new consolidated obligation bonds committed to be issued, for which it is the primary obligor, with trade dates from April 29 to May 1, 2026, totaling $890,000,000 in par value. These fixed-rate bonds carry coupon rates ranging from 3.790% to 5.600%, with maturities from 2026 to 2046 and various optional principal redemption features. This is routine disclosure of debt securities issuance in the capital markets, backed jointly by the eleven Federal Home Loan Banks but not guaranteed by the U.S. government.

  • ·Excludes discount notes with maturity of one year or less issued in ordinary course.
  • ·Schedule A reports principal at par, which may differ from GAAP financial statement amounts.
  • ·Consolidated obligations are joint and several obligations of the eleven Federal Home Loan Banks, regulated by FHFA.
Plante Moran Financial Advisors, LLC13F-HRneutralmateriality 4/10

05-05-2026

Plante Moran Financial Advisors, LLC disclosed total holdings of $1,546,040,882 across 718 positions in its 13F-HR filing as of March 31, 2026. The portfolio features heavy ETF allocations including Vanguard Extended Market ETF at $170,972,880 and Vanguard Large-Cap ETF at $85,786,393, alongside stocks such as Microsoft Corp ($5,603,948), Amazon.com Inc ($2,933,016), and Alphabet Inc ($2,800,315). All reported positions are held solely with no shared voting or investment discretion indicated.

  • ·Filing submitted on May 05, 2026 for quarter ended March 31, 2026.
  • ·Headquartered at 3000 Town Center Dr., Suite 100, Southfield, MI 48075.
  • ·All holdings reported as SOLE discretionary with zero shared voting or investment discretion.
MCDANIEL TERRY & CO13F-HRneutralmateriality 6/10

05-05-2026

McDaniel Terry & Co filed its 13F-HR on May 5, 2026, reporting holdings as of March 31, 2026, with a total portfolio value of $1177174373 across 81 positions, all held with sole voting and dispositive power. Top holdings include Microsoft (109504725 USD), Taiwan Semiconductor ADR (92986605 USD), Apple (88833706 USD), Nordson (62325122 USD), and Amphenol (50905328 USD). No period-over-period changes are disclosed in the filing.

  • ·All 81 positions held with sole shared voting power (0) and sole shared dispositive power (0).
  • ·Firm located at 2630 Exposition Blvd, Suite 300, Austin, TX 78703.
DuPont de Nemours, Inc.10-Qmixedmateriality 8/10

05-05-2026

DuPont's net sales from continuing operations rose 4% YoY to $1,681 million in Q1 2026 from $1,612 million, driving income from continuing operations up 88% to $150 million, while operating cash flow from continuing operations surged 201% to $232 million. However, SG&A expenses increased 9% to $255 million, restructuring charges rose 18% to $46 million, and sundry income fell 64% to $36 million. Overall net income flipped to $164 million from a $581 million loss, aided by discontinued operations improving to a $14 million gain from a $661 million loss.

  • ·Total assets decreased slightly to $21,449 million at March 31, 2026 from $21,575 million at December 31, 2025.
  • ·Long-term debt stable at $3,132 million at March 31, 2026 vs. $3,134 million at December 31, 2025.
  • ·Capital expenditures for continuing operations $102 million in Q1 2026, down from $122 million in Q1 2025.
  • ·Dividends paid to stockholders $82 million in Q1 2026 ($0.20 per share) vs. $172 million in Q1 2025 ($0.41 per share).
POWELL INDUSTRIES INC10-Qmixedmateriality 8/10

05-05-2026

Powell Industries reported Q3 FY2026 revenues of $296,615 (up 6.5% YoY from $278,631), but operating income declined 2.3% to $57,581 due to higher SG&A expenses ($25,843, +18.8% YoY) and R&D ($4,289, +56.2% YoY), resulting in net income of $45,887 (down 0.9% YoY). For the six months ended March 31, 2026, revenues grew 5.4% YoY to $547,799, operating income rose 6.2% to $100,352, and net income increased 7.6% to $87,277, supported by strong operating cash flow of $94,811 (up 59.4% YoY). The balance sheet showed total assets at $1,180,039 (up 6.5% from September 30, 2025) and cash at $537,712.

  • ·Diluted EPS for Q3 FY2026: $1.25 (down from $1.27 YoY); 6M: $2.39 (up from $2.22).
  • ·Stockholders’ equity at March 31, 2026: $709,069 (up 10.7% from $640,770 at Sep 30, 2025).
  • ·Dividends per share Q3: $0.0900 (vs $0.0892 YoY).
SMITH, MOORE & CO.13F-HRneutralmateriality 7/10

05-05-2026

Smith, Moore & Co. disclosed total holdings of $1,374,851,389 across 558 positions in its 13F-HR filing for the quarter ended March 31, 2026. The portfolio is diversified across individual stocks like Apple Inc. ($36,204,212) and Berkshire Hathaway, as well as numerous ETFs including Bondbloxx Bloomberg One Year Target Duration US Treasury ETF ($44,404,231) and various Capital Group ETFs. All positions are held with sole voting and disposition power, with no shared power reported.

  • ·Filing date: May 05, 2026
  • ·Report period end: March 31, 2026
  • ·All holdings reported with sole voting and sole disposition power (no shared or other power)
  • ·Portfolio includes 294 individual stocks and ETFs across sectors like technology, energy, utilities, and fixed income
Philadelphia Investment Partners, LLC13F-HRneutralmateriality 6/10

05-05-2026

Philadelphia Investment Partners, LLC filed its 13F-HR on May 5, 2026, disclosing equity holdings as of March 31, 2026, with a portfolio emphasizing ETFs, technology, energy, and biotech stocks. Top positions include Palantir Technologies valued at $9.51B (65,044 shares), VanEck Vectors Fallen Angel High Yield Bond ETF at $8.94B (311,205 shares), and iShares Ultra Short Duration Bond Active ETF at $5.50B (108,738 shares). No period-over-period changes are detailed in the filing.

  • ·Filing period end date: March 31, 2026
  • ·Filer CIK: 0002131511
  • ·Filer address: 1233 Haddonfield-Berlin Rd. Unit 7, Voorhees, NJ 08043
  • ·Includes put options on ALTC Acquisition Corp (147 shares), Blackstone Group Inc (50 shares), and Centrus Energy Corp (16 shares)
  • ·Includes call options on Tesla Mtrs Inc (10 shares)
Clear Harbor Asset Management, LLC13F-HRneutralmateriality 5/10

05-05-2026

Clear Harbor Asset Management, LLC filed its 13F-HR report on May 5, 2026, for the quarter ended March 31, 2026, disclosing a total portfolio value of $1,449,881,850 across 450 positions, all held with sole voting power. Top holdings include Apple Inc. ($81,887,387 for 322,658 shares), Alphabet Inc. CAP STK CL A ($26,009,497 for 90,448 shares), Amazon.com Inc. ($23,189,615 for 111,344 shares), and American Water Works Co Inc New COM ($22,723,035 for 166,970 shares). The filing reflects a diversified equity portfolio with no reported changes or performance metrics compared to prior periods.

  • ·All positions held with SOLE voting power
  • ·No put or call options dominate; minor positions in puts/calls for Apple, Alphabet, etc.
  • ·Portfolio includes ETFs, common stocks, and ADRs across sectors like tech, healthcare, and utilities
JELD-WEN Holding, Inc.10-Qmixedmateriality 8/10

05-05-2026

JELD-WEN reported Q1 2026 net revenues of $722,125 thousand, down 6.8% YoY from $776,006 thousand, with gross margin declining 17.3% to $92,714 thousand amid higher cost of sales. Operating loss narrowed to $55,222 thousand from $184,951 thousand, primarily due to the absence of a $137,721 thousand goodwill impairment and lower restructuring charges of $1,979 thousand versus $14,546 thousand. Net loss improved to $76,844 thousand ($0.90 per share) from $190,138 thousand ($2.24 per share), though shareholders' equity fell to $12,181 thousand.

  • ·Net cash used in operating activities increased to $91,215 thousand from $83,494 thousand YoY.
  • ·Cash and cash equivalents plus restricted cash decreased to $52,347 thousand from $133,172 thousand YoY.
  • ·Long-term debt increased to $1,189,436 thousand from $1,149,614 thousand QoQ.
Monroe Capital Income Plus CorpDEFA14Aneutralmateriality 4/10

05-05-2026

Monroe Capital Income Plus Corporation has issued additional proxy materials for its Annual Stockholder Meeting scheduled for June 16, 2026, seeking to re-elect Roger Schoenfeld as a Class II Director, with the Board recommending a 'FOR' vote. Stockholders of record as of April 13, 2026, will receive initial communications from Broadridge around May 8th, followed by limited e-mail reminders starting May 15th if needed, with no outbound phone calls planned unless quorum is at risk. Outreach will end upon achieving quorum or after a shareholder casts their vote.

  • ·Proxy communications are not spam and feature Broadridge's logo.
  • ·Shareholders are removed from outreach lists immediately after voting, subject to 1-2 day processing lag by Broadridge.
  • ·Phone solicitation reserved only if below quorum near meeting date.
GuidedMoney, LLC13F-HRneutralmateriality 5/10

05-05-2026

GuidedMoney, LLC filed its 13F-HR on May 5, 2026, disclosing 29 equity holdings as of March 31, 2026, with a total portfolio market value of $190,476,114. Top positions include Vanguard Total Stock Market ETF ($74,997,766; 233,776 shares), Vanguard Total Bond Market ETF ($50,576,099; 686,802 shares), and Vanguard Total International Stock ETF ($16,744,205; 217,147 shares), with all holdings reported under sole voting and disposition power. No period-over-period changes or performance metrics are provided in this quarterly snapshot filing.

  • ·All 29 holdings reported with sole voting power (SH SOLE) and no shared voting or other disposition power.
  • ·Filer CIK: 0002112951, SEC file number: 028-26686.
  • ·Business address: 5293 Scherbel Rd, Black Earth, WI 53515.
Beaumont Financial Advisors, LLC13F-HRneutralmateriality 5/10

05-05-2026

Beaumont Financial Advisors, LLC filed a 13F-HR on May 05, 2026, disclosing its equity holdings as of March 31, 2026, with a total portfolio value of $1,455,127,053 across 369 positions held on a sole basis. The portfolio features significant allocations to large-cap stocks such as Apple Inc. ($65,206,639 for 256,931 shares), Alphabet Inc. Class A ($61,748,087 for 214,731 shares), and Amazon.com Inc. ($31,756,173 for 152,476 shares), alongside diversified ETFs including iShares Core S&P 500 ETF and various sector-specific funds. No prior period comparisons or changes in holdings are detailed in the filing.

  • ·Filing period end date: 03-31-2026
  • ·Filer CIK: 0001957394
  • ·Filer address: 250 1st Avenue, Suite 101, Needham, MA 02494
EXELIXIS, INC.10-Qmateriality 6/10

05-05-2026

KKR Enhanced US Direct Lending Fund-L Inc.8-Kpositivemateriality 7/10

05-05-2026

KKR Enhanced US Direct Lending Fund-L Inc. declared a dividend of $9.74 per share on its common shares of beneficial interest on April 30, 2026. The dividend will be paid on or about May 29, 2026, to shareholders of record as of the close of business on April 30, 2026. This filing was reported on Form 8-K under Item 8.01 Other Events.

SKY-MOUNTAIN CAPITAL MANAGEMENT, INC.13F-HRneutralmateriality 8/10

05-05-2026

Sky-Mountain Capital Management, Inc. filed its 13F-HR report on May 5, 2026, for the period ended March 31, 2026, disclosing 37 equity holdings with a total market value of $139381358000. Largest positions include WisdomTree Floating Rate Treasury ETF ($64059717000), SPDR Gold Shares ($26147432000), and Fidelity Wise Origin Bitcoin Shares ($4978472000), alongside diversified holdings in tech stocks like Apple ($3801567000) and ETFs. All 37 positions are held with sole discretionary voting authority and no reported options activity.

  • ·Report filed as of May 5, 2026
  • ·Central Index Key: 0002065074
  • ·SEC File Number: 028-25527
  • ·All holdings reported as SH SOLE with zero put/call and zero other manager shares
IMC-Chicago, LLC13F-HRneutralmateriality 9/10

05-05-2026

IMC-Chicago, LLC filed its 13F-HR on May 5, 2026, disclosing a portfolio of equity holdings and derivatives as of March 31, 2026, with a total reported value of $278360745305. Key positions include large call and put options on major technology stocks such as Amazon.com Inc (calls valued at 2497282262), Alphabet Inc CAP STK CL A (calls at 2470082888), and Advanced Micro Devices Inc (puts at 1908722661), alongside smaller direct share holdings across various sectors. The filing reveals a market-neutral strategy with balanced long and short derivative exposures but provides no period-over-period comparisons.

  • ·Filing period end date: 2026-03-31
  • ·Business address: 233 South Wacker Street Suite 4300, Chicago, IL 60606
  • ·Phone: 312-244-3313
  • ·SEC file number: 028-13342
Sunstone Hotel Investors, Inc.10-Qmixedmateriality 8/10

05-05-2026

Sunstone Hotel Investors, Inc. reported Q1 2026 total revenues of $259,709, up 10.95% YoY from $234,065, driven by increases in room ($161,047, +11.1%), food and beverage ($74,287, +10.7%), and other operating revenues ($24,375, +10.7%), leading to net income of $18,557, a 253% YoY surge from $5,255. However, total assets declined slightly QoQ to $3,010,143 from $3,029,005, stockholders' equity fell to $1,904,299 from $1,944,618, and debt rose to $942,715 from $918,086 amid share repurchases and financing activities.

  • ·Repurchased 3,184,768 common shares for $29,144 and preferred shares including 242,762 Series H and 122,333 Series I.
  • ·Proceeds from term loans $90,000; payments on senior notes $65,000 in Q1 2026.
  • ·Basic EPS $0.08 in Q1 2026 vs $0.01 in Q1 2025.
Mountain Crest Acquisition 6 Corp.8-Kpositivemateriality 9/10

05-05-2026

Mountain Crest Acquisition 6 Corp., a blank check company (SPAC), announced the pricing of its $60 Million initial public offering of 6,000,000 units at $10.00 per unit, with each unit consisting of one ordinary share and one right entitling the holder to 1/4 of one ordinary share upon initial business combination. Units are expected to begin trading on Nasdaq under 'MCAHU' on April 30, 2026, with closing anticipated on May 1, 2026, subject to customary conditions. D. Boral Capital LLC serves as sole book-running manager, with a 45-day option to purchase up to 900,000 additional units.

  • ·Registration Statement on Form S-1 (File No. 333-294891) declared effective by SEC on April 29, 2026
  • ·Expected separate trading of ordinary shares (MCAH) and rights (MCAHR) on Nasdaq after units separate
ELECTRONIC ARTS INC.8-Kmixedmateriality 9/10

05-05-2026

Electronic Arts Inc. (EA) reported record FY26 net bookings of $8.026 billion, up 9% YoY, and operating cash flow of $2.553 billion, up 23% YoY, driven by the successful Battlefield 6 launch, mid-single-digit growth in Global Football net bookings, and double-digit growth in Apex Legends net bookings. However, FY26 net revenue grew only 1% to $7.531 billion, with live services net revenue declining to $5.383 million from $5.461 million and net income falling 21% to $887 million from $1.121 billion YoY. The company provided an update on its pending $55 billion acquisition by an investor consortium led by The Public Investment Fund, noting ongoing regulatory reviews.

  • ·Quarterly cash dividend of $0.19 per share declared, payable June 17, 2026 to stockholders of record May 27, 2026.
  • ·FY26 value of shares repurchased: $750 million (down from $2,500 million in FY25).
  • ·Total assets as of March 31, 2026: $13.131 billion (up from $12.368 billion).
  • ·Deferred net revenue (online-enabled games) as of March 31, 2026: $2.233 billion.
RIGEL PHARMACEUTICALS INC8-Kmixedmateriality 8/10

05-05-2026

Rigel Pharmaceuticals reported Q1 2026 total revenues of $58.8 million, up from prior year, driven by net product sales of $54.9 million (+26% YoY), with TAVALISSE (+31% to $37.3M) and REZLIDHIA (+31% to $8.0M) showing strong growth, while GAVRETO grew modestly +7% to $9.6M; however, net income declined to $8.7 million from $11.4 million YoY amid higher costs of $46.9 million, and Eli Lilly will terminate their collaboration on ocadusertib effective June 15, 2026. The company reaffirmed 2026 guidance of $275-290M total revenues and positive full-year net income, with cash at $146.7M. Progress continues on R289 Phase 1b study, on track for dose selection in H2 2026.

  • ·Contract revenues from collaborations: $3.9M in Q1 2026 ($1.8M from Grifols royalties, $1.8M from Kissei drug supplies, $0.3M from Medison)
  • ·2026 guidance: Contract revenues $20-25M
  • ·Pralsetinib ORR of 67% (26/39) in RET fusion-positive solid tumors from TAPISTRY study
  • ·Restructured credit: Repaid $40.0M term loan, new $40.0M revolver (expandable to $60.0M)
FEDERAL AGRICULTURAL MORTGAGE CORP8-Kpositivemateriality 9/10

05-05-2026

Farmer Mac reported record outstanding business volume of $34.8 billion, up 17% YoY, with broad-based growth across all segments including Renewable Energy (+80% YoY) and Broadband Infrastructure (+73% YoY). Net interest income rose 11% YoY to $101.4 million but declined 3% QoQ from $104.5 million, while net income attributable to common stockholders increased to $51.8 million or $4.75 per diluted share, up 18% YoY and 28% QoQ. Net effective spread and core earnings grew 13% YoY, supported by $1.5 billion net portfolio growth.

  • ·Total core capital of $1.7 billion with Tier 1 Capital Ratio of 13.0% as of March 31, 2026
  • ·Purchased $45.0 million of tax credits, resulting in a $4.2 million benefit
  • ·Operating efficiency ratio below long-term strategic target
  • ·Credit provisions primarily related to new volume growth and portfolio credit migration in Agricultural Finance
  • ·Farm & Ranch portfolio grew $675.3 million (loans +$383.9M, AgVantage +$325.0M)
  • ·Renewable Energy business volume increased $444.5 million
  • ·Broadband Infrastructure business volume grew $158 million
EXELIXIS, INC.8-Kpositivemateriality 9/10

05-05-2026

Exelixis reported Q1 2026 total revenues of $610.8 million, up 10% YoY from $555.4 million, driven by cabozantinib franchise U.S. net product revenues of $555.0 million (up 8% from $513.3 million), while collaboration revenues rose 32% to $55.8 million. GAAP diluted EPS increased to $0.79 from $0.55 and non-GAAP to $0.87 from $0.62, with R&D expenses decreasing 6% to $199.9 million; however, SG&A expenses edged up 2% to $139.6 million. The company announced a new $750 million stock repurchase program through 2027 and provided updates on zanzalintinib pipeline milestones, including FDA acceptance of NDA for metastatic CRC with PDUFA date of December 3, 2026.

  • ·2026 guidance: Total revenues $2.525B - $2.625B; Net product revenues $2.325B - $2.425B; R&D $875M - $925M; SG&A $575M - $625M; Effective tax rate 21%-23%.
  • ·October 2025 SRP: $590.6M repurchased at average $43.14 per share as of Q1 2026 end, expected completion in May 2026.
  • ·STELLAR-304 topline results expected H2 2026; STELLAR-316 initiation mid-2026; STELLAR-202 and STELLAR-002 expansion H2 2026.
  • ·FDA PDUFA target for zanzalintinib NDA in metastatic CRC: December 3, 2026.
QuidelOrtho Corp8-Kmixedmateriality 9/10

05-05-2026

QuidelOrtho reported Q1 2026 total revenue of $620 million, down 10% YoY from $693 million, with Point of Care revenue declining 34% to $113 million due to a weaker respiratory season, Labs revenue falling 5% to $353 million amid China distributor slowdowns and Middle East disruptions, but Immunohematology revenue growing 8% to $138 million. The company posted a GAAP net loss of $92 million and adjusted EBITDA of $109 million, while completing the LEX Diagnostics acquisition and launching key products like High-Sensitivity Troponin in the US. Full-year 2026 guidance was lowered to $2.70-$2.75 billion in revenue and $615-$630 million adjusted EBITDA, reflecting China NHSA pricing concerns.

  • ·GAAP diluted loss per share of $(1.35) vs $(0.19) in Q1 2025; adjusted diluted loss per share of $(0.04).
  • ·Cash used for operating activities $(33.0) million in Q1 2026 vs provided $65.6 million in Q1 2025.
  • ·Updated FY2026 adjusted EBITDA guidance $615-$630 million (23% margin) vs prior $630-$670 million.
  • ·Updated FY2026 adjusted diluted EPS guidance $1.80-$2.00 vs prior $2.00-$2.42; free cash flow $100-$120 million vs prior $120-$160 million.
Intapp, Inc.8-Kmixedmateriality 9/10

05-05-2026

Intapp reported Q3 FY2026 SaaS revenue of $107.9 million, up 27% YoY, total revenue of $146.0 million, up 13% YoY, Cloud ARR of $459.3 million, up 31% YoY, and total ARR of $559.9 million, up 23% YoY, with cloud net revenue retention at 123%. However, GAAP operating loss widened to $(14.2) million from $(5.7) million YoY, GAAP net loss increased to $(15.5) million from $(3.0) million, and license revenue declined to $24.8 million from $31.7 million. Non-GAAP metrics showed improvement with operating income of $25.7 million (up from $20.3 million) and net income of $23.7 million (up from $21.7 million).

  • ·Q4 FY2026 guidance: SaaS revenue $113.1-$114.1M; total revenue $149.1-$150.1M; non-GAAP operating income $28.4-$29.4M; non-GAAP diluted net income per share $0.36-$0.38.
  • ·FY2026 guidance: SaaS revenue $421.0-$422.0M; total revenue $574.3-$575.3M; non-GAAP operating income $102.7-$103.7M; non-GAAP diluted net income per share $1.22-$1.24.
  • ·Nine months ended Mar 31, 2026: net cash from operating activities $100.6M (vs $85.2M prior year).
Edgemode, Inc.8-Kneutralmateriality 5/10

05-05-2026

On May 5, 2026, Edgemode, Inc. appointed Simon Kiero-Watson to its Board of Directors to fill a vacancy created by a prior director's resignation in September 2025; he will serve until the next annual stockholder meeting or earlier resignation/removal. Mr. Kiero-Watson, Head of Markets at Tokenise Group since April 2021 and director of several Tokenise-related entities since June 2018, will receive 10,000,000 shares of restricted common stock as compensation under an Independent Director Agreement, with standard indemnification. No arrangements, understandings, or material transactions involving Mr. Kiero-Watson and the Company were disclosed.

  • ·Vacancy on Board created by prior director's resignation in September 2025.
  • ·Mr. Kiero-Watson has held directorships since June 2018.
  • ·No transactions with the Company in which Mr. Kiero-Watson had or will have a direct or indirect material interest per Item 404(a) of Regulation S-K.
EMERSON ELECTRIC CO10-Qmixedmateriality 8/10

05-05-2026

Emerson Electric Co reported net earnings of $618 million for the three months ended March 31, 2026, up 43.7% YoY from $430 million, and $1,224 million for the six months, up 19.8% YoY from $1,022 million. However, comprehensive income attributable to common stockholders declined 13.5% YoY to $585 million in the quarter due to foreign currency translation losses, while cash provided by operating activities for the six months improved 45.2% to $1,478 million. Total assets edged up to $42,088 million, but changes in operating working capital deteriorated to a $613 million use from $203 million.

  • ·Depreciation and amortization six months 2026: $728M, down from $767M YoY.
  • ·Capital expenditures six months 2026: $182M.
  • ·Common stock repurchases six months 2026: $548M.
  • ·Dividends paid six months 2026: $627M ($1.11 per share).
  • ·Amortization of intangibles three months 2026: $205M, down from $229M YoY.

Get daily alerts with 12 investment signals, 8 risk alerts, 10 opportunities and full AI analysis of all 50 filings

More from: S&P 500 Consumer Staples Sector SEC Filings

🇺🇸 More from United States

View all →